Roche vs Tesla: Founders, CEOs and History
Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker. Tesla was founded in 2003 by Martin Eberhard, Marc Tarpenning, Elon Musk and is led by Elon Musk.
Company facts
Founders
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
Tesla
Martin Eberhard
Martin Eberhard is an American electrical engineer who co-founded Tesla Motors and was its first CEO. He had earlier co-founded NuvoMedia, the company that made the Rocket eBook.
Marc Tarpenning
Marc Tarpenning co-founded Tesla Motors in 2003 and served in early finance, engineering and operating roles, including CFO and vice president of engineering.
Elon Musk
Elon Musk's role in Tesla's founding story is best understood as financier, chairman, product force and later crisis CEO.
JB Straubel
JB Straubel became Tesla's founding CTO and one of the most important technical architects in the company's history.
Ian Wright
Ian Wright is listed among Tesla's early founding figures because he contributed to the company's initial vehicle thinking and engineering direction.
CEOs and their tenures
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Tesla
- Martin Eberhard2003–2007
Chief Executive Officer
Served as founding CEO from 2003 to August 2007, establishing the core technical thesis of high-performance electric vehicles and directing early engineering on the EP1 and EP2 Roadster prototypes before development delays and cost overruns prompted a board re…
Source - Ze'ev Drori2007–2008
Chief Executive Officer
Served as CEO from November 2007 to October 2008 during Tesla's initial manufacturing transition, bringing the Roadster from troubled prototypes into customer deliveries and establishing production discipline before handing leadership to Elon Musk.
Source - Elon Reeve Musk2008–present
CEO
Led Tesla's transformation from a niche electric roadster project into the world's leading EV manufacturer, scaling global Gigafactories, Supercharger infrastructure, and autonomous driving architectures.
Source
Timeline: Roche and Tesla side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
2003Tesla
Tesla Motors Founded
Tesla Motors was founded in 2003 by Martin Eberhard and Marc Tarpenning to prove that lithium-ion batteries could power a desirable electric car.
2004Tesla
Elon Musk Leads Series A
Elon Musk led Tesla's Series A financing in 2004 and became chairman. The investment gave Tesla enough capital and public credibility to continue Roadster development.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2008Tesla
Roadster Launch
The Roadster launched in 2008 as a highway-capable electric sports car with more than 200 miles of range. It mattered because it proved an EV could be fast, premium and emotionally desirable.
2008Tesla
Elon Musk Becomes CEO
Musk became CEO in 2008 during a severe financing and production crisis. He restructured operations, secured emergency funding and pushed the company toward a clearer product sequence.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2010Tesla
Tesla IPO
Tesla went public in 2010, raising capital while still far from stable profitability. The IPO mattered because it gave Tesla access to public-market funding for product development and manufacturing.
2012Tesla
Model S Launch
The Model S launched in 2012 and moved Tesla beyond the Roadster niche. It mattered because it combined range, software, performance and premium design in a vehicle Tesla controlled more fully.
2014Tesla
Gigafactory Strategy Announced
Tesla announced the Gigafactory strategy in 2014 with Panasonic as a key partner. The move mattered because batteries were the limiting input for EV scale, cost and range.
2016Tesla
SolarCity Acquired
Tesla's 2016 SolarCity acquisition is company-specific because it changed the portfolio rather than simply adding scale. The reported value was $2.6B.
2017Tesla
Model 3 Production Crisis
The Model 3 ramp in 2017 exposed severe bottlenecks caused partly by excessive automation. The crisis mattered because Tesla's mass-market strategy depended on producing a lower-priced vehicle at high volume.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2020Tesla
S&P 500 Inclusion
Tesla joined the S&P 500 in 2020 after proving sustained profitability. The milestone mattered because it brought index-fund ownership, wider institutional attention and validation that Tesla was no longer a speculative startup.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2023Tesla
Global Price Cuts
Tesla cut prices across major markets in 2023 to defend demand and pressure competitors. The move mattered because it showed Tesla could use its direct-sales model to adjust faster than dealer-based rivals.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2025Tesla
$94.8B Revenue and Delivery Decline
In FY2025, Tesla reported $94.8B in revenue and delivered 1,636,129 vehicles. The milestone mattered because revenue and deliveries both showed the company had entered a more mature, contested phase.
Acquisitions
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Tesla
- Maxwell Technologies2019$218M
- DeepScale2019Undisclosed
- Hibar Systems2019Undisclosed
- Perbix Machine Company2017$10.5M
- SolarCity2016$2.6B
- Grohmann Engineering2016$135M
Questions about Roche vs Tesla
Who is the CEO of F. Hoffmann-La Roche AG and Tesla, Inc.?
F. Hoffmann-La Roche AG is led by Thomas Schinecker and Tesla, Inc. is led by Elon Musk. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was F. Hoffmann-La Roche AG founded vs Tesla, Inc.?
F. Hoffmann-La Roche AG was founded in 1896 — 107 years before Tesla, Inc., which was founded in 2003. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Tesla, Inc..
How many employees does F. Hoffmann-La Roche AG have compared to Tesla, Inc.?
F. Hoffmann-La Roche AG employs approximately 112,774 people, while Tesla, Inc. employs approximately 134,785. Tesla, Inc. has the larger workforce at 134,785 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are F. Hoffmann-La Roche AG and Tesla, Inc. headquartered?
F. Hoffmann-La Roche AG is headquartered in Switzerland and Tesla, Inc. is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded F. Hoffmann-La Roche AG and Tesla, Inc.?
F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche. Tesla, Inc. was founded by Martin Eberhard, Marc Tarpenning, Elon Musk, JB Straubel, Ian Wright.
Which company has a longer operating history — F. Hoffmann-La Roche AG or Tesla, Inc.?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Tesla, Inc. has been in operation for around 23 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Roche vs Tesla overview